Pfizer launches new antibiotic in the UK
Pfizer’s antibiotic Zavicefta has now been launched in the UK to treat serious aerobic Gram-negative infections caused by resistant bacteria.
Read Moreby Selina McKee | Mar 15, 2017 | News | 0
Pfizer’s antibiotic Zavicefta has now been launched in the UK to treat serious aerobic Gram-negative infections caused by resistant bacteria.
Read Moreby Selina McKee | Jan 31, 2017 | News | 0
The US Food and Drug Administration has agreed to expand the label of Dublin, Ireland-based Allergan’s Avycaz to include the treatment of complicated urinary tract infections (cUTI).
Read Moreby Selina McKee | Jul 22, 2016 | News | 0
A late-stage study has confirmed the efficacy of AstraZeneca’s new combination antibiotic Zavicefta in patients with hospital acquired pneumonia (HAP), including ventilator associated pneumonia (VAP).
Read Moreby Selina McKee | Jun 29, 2016 | News | 0
AstraZeneca’s Zavicefta has been approved for use in the European Union to treat patients with serious Gram-negative bacterial infections requiring hospitalisation.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
